Omeros (OMER) Interest Coverage Ratio (2010 - 2026)

Omeros (OMER) posted Interest Coverage Ratio of 2.96 for Q1 2026, up 30.6% sequentially from 4.26 in Q4 2025, and up 13.63% YoY from 2.6 in Q1 2025.

Omeros (OMER) Interest Coverage Ratio (2010 - 2026) Analysis & Trends

Omeros has reported Interest Coverage Ratio for 17 years, with the latest figure at 2.96 in Q1 2026.

Quarterly Interest Coverage Ratio rose 13.63% year-over-year to 2.96 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.39 (up 22.64% YoY) and the FY2025 annual result came in at 0.67, up 77.51% from the prior year.
Interest Coverage Ratio improved to 2.96 in Q1 2026 per OMER's latest filing, from 4.26 in the prior quarter.
Over five years, Interest Coverage Ratio peaked at 3.81 in Q4 2022 and troughed at 32.89 in Q4 2024.
A 5-year average of 5.98 and a median of 4.74 in 2024 frame the typical range for Interest Coverage Ratio.
The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio soared 257.53% in 2022, then slumped 1718.48% in 2024.
Over 5 years, Interest Coverage Ratio stood at 3.81 in 2022, then sank by 147.49% to 1.81 in 2023, then plunged by 1718.48% to 32.89 in 2024, then surged by 87.05% to 4.26 in 2025, then soared by 30.6% to 2.96 in 2026.
According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.96, 4.26, and 1.22 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	2.84
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	24.64
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-0.19
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	8.18
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-0.01
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.61
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	2.82
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-0.08
10	Omeros	1.24 Bn	1.24 Bn	27.73 Mn	0.00

Download Data